Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection

Medical Mycology

Volumn 41, Issue 5, 2003, Pages 401-409

  Wormley, Floyd L ^a   Cutright, Jessica ^a   Fidel, Paul L ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Cell mediated immunity; Knockout mice; Vaginal candidiasis

Indexed keywords

CANDIDA ALBICANS ANTIGEN; CANDIDA ANTIGEN; ESTROGEN; FREUND ADJUVANT; GENTAMICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PROTECTION; STRAIN DIFFERENCE; T LYMPHOCYTE; VAGINA CANDIDIASIS; WILD TYPE;

ANIMALS; ANTIGENS, CD4; CANDIDIASIS, VULVOVAGINAL; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MICE, SCID; T-LYMPHOCYTES; TIME FACTORS;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MUS MUSCULUS;

EID: 0344876479     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/3693780310001597683     Document Type: Article

References (34)

1. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-647.
2. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 1988; 544: 547-557.
3. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14: S148-S153.
4. Fidel Jr PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335-348.
5. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 354-357.
6. Fidel Jr PL, Lynch ME, Sobel JD. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun 1994; 62: 1032-1038.
7. Fidel Jr PL, Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547-553.
8. Fidel Jr PL, Luo W, Steele C, Chaiban J, Baker M, Wormley FL. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun 1999; 67: 3135-3140.
9. Wormley Jr FL, Chaiban J, Fidel Jr PL. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun 2001; 69: 5072-5079.
10. Wormley Jr FL, Steele C, Wozniak K, Fujihashi K, McGhee JR, Fidel Jr PL. Resistance of TCR Ì-chain knock-out mice to experimental Candida vaginitis. Infect Immun 2001; 69: 7162-7164.
11. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Ann Rev Immunol 1998; 16: 137-161.
12. + Th1/Th2 T cells. Eur J Immunol 2000; 30: 2101-2111.
13. Fidel Jr PL, Barousse M, Espinosa T, Chesson RR, Dunlap K. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle. Med Mycol 2003; 41: 97-109.
14. Taylor BN, Saavedra M, Fidel Jr PL. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. J Med Mycol 2000; 38: 419-431.
15. Fidel Jr PL, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997; 176: 728-739.
16. Fidel Jr PL, Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun 1993; 61: 1990-1995.
17. Domer JE, Garner R E, Befidi-Mengue RN. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect Immun 1989; 57: 693-700.
18. Fidel Jr PL, Wolf NA, KuKuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 1996; 64: 3793-3799.
19. Fidel Jr PL, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403-2408.
20. Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol 1997; 36: 23-50.
21. Cardenas-Freytag L, Steele C, Wormley FL Jr, Cheng E, Clements JD, Fidel PL Jr. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol 2002; 40: 291-300.
22. Gould DS, Ploegh HL, Schust DJ. Murine female reproductive tract intraepithelial lymphocytes display selection characteristics distinct from both peripheral and other mucosal T cells. J Reprod Immunol 2001; 52: 85-99.
23. Cantorna MT, Mook D, Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidasis. Infect Immun 1990; 58: 3813-3815.
24. Black CA, Eyers FM, Russell A, Dunkley ML, Clancy RL, Beagley KW. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J Reprod Immunol 1999; 45: 1-18.
25. Fidel Jr PL, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168: 1458-1465.
26. Leigh JE, Barousse M, Swoboda RK, et al. Candida-specific systemic cell-mediated immune reactivities in HIV-infected persons with and without mucosal candidiasis. J Infect Dis 2001; 183: 277-285.
27. Fidel Jr PL, Cutright JL, Sobel JD. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect Immun 1995; 63: 4191-4194.
28. Mulero-Marchese RD, Blank KJ, Sieck TG. Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization. J Infect Dis 1998; 178: 227-234.
29. De Bernardis F, Santoni G, Boccanera M, et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 2000; 68: 3297-3304.
30. Cassone A, Boccanera M, Adriana DA, Santoni G, De Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal infection. Infect Immun 1995; 63: 2619-2624.
31. Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997; 65: 3399-3405.
32. Hawkins RA, Rank RG, Kelly KA. Expression of mucosal homing receptor �4β7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun 2000; 68: 5587-5594.
33. Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997; 65: 5198-5208.
34. Milligan GN, Bernstein DI. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997; 229(1): 259-268.